The overexpression of SOX2, which is a CSC-associated gene, stimulated cell proliferation, migration, resistance to cisplatin treatment, and the tumorigenicity of ovarian cancer cells [120]. The gene discussed is SOX2; the disease is ovarian carcinoma.